HomeREGULATORY
REGULATORY

MHLW OKs Add’l Indications for Keytruda, Soliris and More
(Dec.26.2017)

The Ministry of Health, Labor and Welfare (MHLW) on December 25 approved additional indications for a batch of drugs, including MSD’s anti-PD-1 antibody Keytruda (pembrolizumab) for the treatment of unresectable urothelial cancer ...
(LOG IN FOR FULL STORY)